We are live on
!
Find out more
TCM
Tang Capital Management Portfolio holdings
AUM
$2.2B
1-Year Est. Return
156.35%
This Fund
S&P 500
This Quarter
Est. Return
-11.42%
1 Year Est. Return
+156.35%
3 Year Est. Return
+492.92%
5 Year Est. Return
+804.3%
10 Year Est. Return
+3,997.35%
AUM
$271M
AUM Growth
-$58.4M
(-18%)
Cap. Flow
-$36.9M
Cap. Flow
% of AUM
-13.63%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
1
Reduced
–
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Opko Health
OPK
|
+$32.8M |
| 2 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
+$7.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BRLI
BIO-REFERENCE LABS INC-NEW-
BRLI
|
+$37.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 91.33% |
| 2 | Miscellaneous | 8.67% |
Similar funds
LI
MIHAS
1SB
BOI
IHL
PCM
BCP
AAA
Tang Capital Management's Q3 2015 Portfolio in Review
As of Q3 2015, Tang Capital Management held 7 positions worth $271M, down 18% from $330M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Tang Capital Management withdrew a net $36.9M in Q3 2015, closing 1 position. Its most notable exit was BIO-REFERENCE LABS INC-NEW-, an estimated $37.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 91% of assets, up from 76% a quarter earlier, followed by Miscellaneous.
Against the trend, Tang Capital Management opened a new position in Opko Health worth $20.8M.
- Tang Capital Management's largest Q3 2015 buy was Opko Health: 2,475,000 shares worth $20.8M.
- Tang Capital Management added most to La Jolla Pharmaceutical Company in Q3 2015, an estimated $7.88M increase.
- Tang Capital Management fully exited BIO-REFERENCE LABS INC-NEW- in Q3 2015, selling an estimated $37.1M.
- Tang Capital Management's ten largest holdings make up 100% of its $271M portfolio in Q3 2015.
- Tang Capital Management opened 1 new position and closed 1 in Q3 2015.
- Tang Capital Management's portfolio value fell 18% quarter-over-quarter to $271M.
Based on Tang Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.